India: Emcure Pharma buys out Canada’s IPG and its marketing arm

Pune-based drug company Emcure Pharmaceuticals has acquired Canada’s International Pharmaceutical Generics Ltd. (IPG) and its marketing arm Marcan Pharmaceuticals, according to a report in The Economic Times.

These acquisitions will give the Indian pharmaceutical company an entry into the Canadian market.

Emcure, which recently estimated its annual global sales at over $670 million, makes a range of drugs such as Asomex, used to treat blood pressure. Cardiology, gynaecology and anti-infective medicines account for a bulk of its portfolio.

The company currently has nine manufacturing plants, including one in the US, and exports to a number of countries including the US, Europe, Brazil and Japan.

IPG is in the business of licensing, importing and distributing prescription pharmaceutical and over the counter finished formulations in Canada. Since the launch of its first product in 2007, the company has grown to offer over 40 products covering a range of therapeutic categories.

Marcan Pharma claims to have over 60 approved products that are mainly available via McKesson and Kohl & Frisch, among other wholesalers, the report said.

Also Read: Indian online pharmacy startups attract investor interest despite regulatory concerns

Petition against Sun Pharma for allegedly violating Ranbaxy merger terms

India: PE firm Everstone Capital in talks to invest $60m in pharmacy delivery startup Dial Health

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.